Antares: Reiteration Of My Buy Recommendation [View article]
Never before has so much been written about something that has delivered so little for so long and whose delivery time horizon keep sgetting pushed further and further and...
New York Mortgage Trust (NYMT) announces a big 13.6M share secondary - together with the underwriters option, it will add about 30% to the float. The company estimates Q1 GAAP income of $0.28-$0.31/share which includes $0.12-$0.15 of unrealized gains thanks to narrowing credit spreads on its book of multi-family loans. March 31 book value/share is estimated at $6.53-$6.56. Shares -5% AH to $7.01. [View news story]
I don't think so. If you do the math they seem to be pricing the shares at $7.16
Newcastle Investment Corporation: Buying Opportunity In An 8.8% Yielder [View article]
Have you looked at the MACD chart for NCT? I don't think it indicates that this is a good time to buy. Looks to me that it has some more value to lose before it starts to recover. Then it would be a good buying opportunity.
American Realty Capital Properties Gets Too Ambitious [View article]
The more I read about this the more I am considering dumping my shares. I get the impression someone at ARCP has gotten hiself into a stare down contest and in the end the Cole people will be laughing all the way to the bank.
/C O R R E C T I O N -- American Realty Capital Properties, Inc./ [View article]
Not surprised by this but I agree with Brad Thomas' recent article where he came out in opposition to this deal because ARCP would be handling types of properties it has no experience with. My own opinion is that ARCP is moving too quickly. Might be time to take profits and wait until the dust settles.
A Deep Dive Into Antares Pharma's Buyout Thesis [View article]
You make the case for reducing costs -"Some examples of such chronic conditions are anemia, diabetes, multiple sclerosis, human growth deficiency, rheumatoid arthritis, hepatitis, and migraine. Patients usually visit the office of a healthcare provider to receive their injections. Repeated visits to a healthcare provider results in high costs as each office visit is charged separately. Government and managed care providers are increasingly looking for ways to contain the higher costs associated with such chronic conditions. It is not only the monetary cost that is involved here. One needs to take into account the inconvenience, lost productivity of the patient while going to doctor's office, and transportation costs too." Now, I don't know about all of the ill's you cite but I do know about diabetes. I know several people with this disease including my wife and son and not one of them goes to a doctor's office for an injection. My son has been injecting 3 or 4 times a day for over 30 years. I hope your other assumptions are based on more reliable information
American Realty Capital Properties: David Acquires Goliath [View article]
How much is 477mm? What does MFFO and FFO stand for. I'm just a lowly Electronics Engineer with no training in accounting. I wish you would define your terms, as is done in most technical articles, when you first use them. I would really like to understand this article because I think that if this sale goes through, ARCP stock is going to take an initial huge hit - much bigger than it did about a week ago when the other merger took place.
Obagi Medical Products Acquired Wednesday, These Biotechs May Be Next [View article]
Now: If Ifs and Buts were candy and nuts every day would be Christmas. Don M, ,Monday Night Football --- a long time ago. Come om Scott - give it a rest.
Dwindling Cash And Risky Bets - New York Mortgage Trust May Roll Craps [View article]
Stock Skeptic: I read your last article recommending people to sell before they made another stock offering. Well -- I took your advice and it cost me about $1000.00.
Antares: Reiteration Of My Buy Recommendation [View article]
4 Mid-Cap Dividend Stocks Yielding Over 6% [View article]
New York Mortgage Trust (NYMT) announces a big 13.6M share secondary - together with the underwriters option, it will add about 30% to the float. The company estimates Q1 GAAP income of $0.28-$0.31/share which includes $0.12-$0.15 of unrealized gains thanks to narrowing credit spreads on its book of multi-family loans. March 31 book value/share is estimated at $6.53-$6.56. Shares -5% AH to $7.01. [View news story]
Newcastle Investment Corporation: Buying Opportunity In An 8.8% Yielder [View article]
High-Yield Dividend Investing Misconceptions [View article]
4 Dividend Stocks For A Safe Retirement Portfolio [View article]
American Realty Capital Properties Gets Too Ambitious [View article]
/C O R R E C T I O N -- American Realty Capital Properties, Inc./ [View article]
A Deep Dive Into Antares Pharma's Buyout Thesis [View article]
American Realty Capital Properties: David Acquires Goliath [View article]
American Realty Capital Properties: David Acquires Goliath [View article]
American Realty Capital Properties: David Acquires Goliath [View article]
Obagi Medical Products Acquired Wednesday, These Biotechs May Be Next [View article]
Will The Energy Transfer Partners/Equity 'Hot Mess' Work Out For Investors? [View article]
Dwindling Cash And Risky Bets - New York Mortgage Trust May Roll Craps [View article]